Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer
Clinical trial NCT03651271 · COMPLETED
Trial details
- NCT number
- NCT03651271
- Sponsor
- Parker Institute for Cancer Immunotherapy
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2023-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.